RecallRadar

FDA Device recall Z-1150-2023

Atellica IM Folate 700 test kit- For in vitro diagnostic use in the quantitative determination of folate in human serum and red blood cells

On 2023-03-01 the FDA classified a Class II recall of Atellica IM Folate 700 test kit- For in vitro diagnostic use in the quantitative determination of folate in human serum and red blood cells by Siemens Healthcare Diagnostics, citing negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1150-2023
ClassificationClass II
Statusongoing
Initiated2023-01-09
Published2023-03-01
Last updated2026-09-13 11:56 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

Atellica IM Folate 700 test kit- For in vitro diagnostic use in the quantitative determination of folate in human serum and red blood cells. Siemens Material Number (SMN): 10995573

Reason

Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

Identifiers

code_info
UDI: (01)00630414598970(10)15307337(17)20230320; (01)00630414598970(10)27948339(17)20230529; (01)00630414598970(10)41…UDI: (01)00630414598970(10)15307337(17)20230320; (01)00630414598970(10)27948339(17)20230529; (01)00630414598970(10)41142343(17)20230630; (01)00630414598970(10)62968345(17)20230726. Lot Numbers: 15307337, 27948339, 41142343, 62968345 and higher. All current and future lots of the ADVIA Centaur Folate assay until the Instructions for Use are updated

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1150-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.